嘗高美集團(08371.HK)預期前三季度收入增長超73%
格隆匯1月20日丨嘗高美集團(08371.HK)公吿,截至2021年12月31日止九個月,預期集團將錄得大幅增長:收入較截至2020年12月31日止九個月增長超過73%;及未經調整淨利潤增長超過145%,扣除政府補助及加回上市費用後淨利潤增長超過395%。
增加原因主要受惠於:(1)本期間開設的更多餐廳以及去年開業的餐廳在本期間貢獻了完整九個月的營業額;(2)人均消費增加;(3)香港政府實施限制性社交距離措施改變了顧客用餐習慣,顧客傾向提前進食晚餐;及(4)於同期期間,在2020年7月下旬至2020年8月底以及在2020年12月初至2021年2月初執行下午6點後禁止堂食。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.